VITROCELL® Cloud Alpha Family

The VITROCELL® Cloud α series for automated exposure of cell cultures has been enlarged and now comprises the Cloud Alpha 6, Cloud Alpha 12, Cloud Alpha 96 and Cloud Alpha MAX. […]

Weiterlesen

VITROCELL® 12/12 now available with Climatic Chamber

The VITROCELL® 12/12 module system has been designed to facilitate the exposure of mammalian cell cultures to airborne substances such as gases, complex mixtures, nanoparticles and fibers. It features a throughput […]

Weiterlesen

New Video: VITROCELL® Cloud α – for Aerosol Research and Cell Exposure at the Air/Liquid Interface (ALI)

The VITROCELL® Cloud Alpha series is our newest innovation and presents a great leap forward in automated exposure of cell cultures. It combines reliable exposure of cell cultures from the […]

Weiterlesen

VITROCELL® Shisha Testing System for Cell Cultures

. Background Emissions of water pipe tobacco can now be tested by in vitro exposure in a reliable and user-­friendly setup. The novel Shisha Testing Device can be combined with […]

Weiterlesen

VITROCELL® Cloud Alpha 96

The VITROCELL® Cloud Alpha 96 is our newest innovation and presents a great leap forward in automated exposure of cell cultures. It combines high throughput testing with ease of use. […]

Weiterlesen

VITROCELL® holder systems for e-cigarettes

New designs of electronic cigarettes such as ENDS (Electronic Nicotine Delivery Systems) products or HTP (Heated Tobacco Products) lead to a large variety of different shapes which make the insertion […]

Weiterlesen

VITROCELL® TEM Grid holders for dose determination of airborne particles during in vitro Exposure at the air / liquid interface

. Background The assessment of toxicological effects of airborne particles to the human organism is of major importance in disease research. The presence of nano and ultrafine particles can be […]

Weiterlesen

Screening antiviraler pharmazeutischer Leitwirkstoffe gegen das Coronavirus (COVID-19 / SARS-CoV-2)

In der Inhalationstherapie werden pharmazeutische Präparate als Aerosole auf Zellen des Atemtraktes im Nasen- oder Lungenbereich appliziert. Zur präklinischen Entwicklung neuer Arzneimittel werden dafür oft kommerziell erhältliche, physiologisch relevante in […]

Weiterlesen